Japan, June 10 -- LENTIGEN TECHNOLOGY INC has got intellectual property rights for 'COMPOSITIONS AND METHODS FOR TREATING CANCER WITH DUOCARS.' Other related details are as follows:
Application Number: JP,2024-005142
Category (FI): A61K35/76,A61K39/395@U,A61K40/11,A61K40/19,A61K40/31,A61K40/42,A61K40/50,A61K39/395@G,A61K39/395@N,A61K39/395@D,A61K47/68,A61K39/395@T,A61K39/395@E,C12N15/86@Z,C12N15/12,C12N15/13,C12N15/62@Z,A61K35/15,A61K35/17,A61K48/00,A61P43/00,105,A61P43/00,121,A61P35/02,A61P35/00,A61P37/04,A61P29/00,A61P37/06,A61P37/08,A61P17/00,A61P25/28,A61P25/16,A61P25/00,A61P11/00
Stage: Grant (IP right document published.)
Filing Date: Jan. 17, 2024
Publication Date: April 16, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
